Published in Am J Respir Cell Mol Biol on March 16, 2006
Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proc Natl Acad Sci U S A (2014) 1.23
The Mycobacterium tuberculosis cytochrome P450 system. Arch Biochem Biophys (2009) 1.16
Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae. Antimicrob Agents Chemother (2008) 0.88
Drug Strategies Targeting CYP51 in Neglected Tropical Diseases. Chem Rev (2014) 0.86
Analysis of the ergosterol biosynthesis pathway cloning, molecular characterization and phylogeny of lanosterol 14 α-demethylase (ERG11) gene of Moniliophthora perniciosa. Genet Mol Biol (2014) 0.77
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem (1964) 24.57
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES. J Biol Chem (1964) 8.70
Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med (1997) 8.10
Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med (1989) 5.79
Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev (1999) 5.51
The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis (1989) 3.14
Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest (2004) 3.13
Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci U S A (2001) 2.90
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis (2004) 2.44
Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest (1994) 2.29
Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J Clin Microbiol (1995) 1.96
Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1999) 1.60
Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest (2005) 1.49
The role of sterols in plant growth and development. Prog Lipid Res (2003) 1.47
Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis (2004) 1.32
Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med (2002) 1.30
Sterol 14-demethylase P450 (P45014DM*) is one of the most ancient and conserved P450 species. J Biochem (1996) 1.29
Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans. Biochem J (1990) 1.27
Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis. FEMS Microbiol Lett (2000) 1.26
Electron paramagnetic resonance detectable states of cytochrome P-450cam. Biochemistry (1980) 1.22
Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis (1991) 1.15
Molecular aspects of azole antifungal action and resistance. Drug Resist Updat (1999) 1.12
Lanosterol 14 alpha-methyl demethylase. Isolation and characterization of the third metabolically generated oxidative demethylation intermediate. J Biol Chem (1991) 1.07
A sterol biosynthetic pathway in Mycobacterium. FEBS Lett (1998) 1.01
Pyrazinamide is not active in vitro against Mycobacterium avium complex. Am Rev Respir Dis (1986) 1.01
Sterol 14-demethylase P450 (CYP51) provides a breakthrough for the discussion on the evolution of cytochrome P450 gene superfamily. Biochem Biophys Res Commun (2000) 1.00
Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole. Microbiology (2005) 0.98
Molecular diversity of sterol 14alpha-demethylase substrates in plants, fungi and humans. FEBS Lett (1998) 0.95
Conservation and cloning of CYP51: a sterol 14 alpha-demethylase from Mycobacterium smegmatis. Biochem Biophys Res Commun (2003) 0.92
Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis. J Biol Chem (2004) 0.91
Hot tub lung: infection, inflammation, or both? Semin Respir Infect (2003) 0.90
Optimized expression and catalytic properties of a wheat obtusifoliol 14alpha-demethylase (CYP51) expressed in yeast. Complementation of erg11Delta yeast mutants by plant CYP51. Eur J Biochem (1999) 0.89
Different substrate specificities of lanosterol 14a-demethylase (P-45014DM) of Saccharomyces cerevisiae and rat liver for 24-methylene-24,25-dihydrolanosterol and 24,25-dihydrolanosterol. Biochem Biophys Res Commun (1991) 0.89
Mechanistic studies of lanosterol 14 alpha-methyl demethylase: substrate requirements for the component reactions catalyzed by a single cytochrome P-450 isozyme. J Lipid Res (1989) 0.88
Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi. J Med Chem (2003) 0.88
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii. Am J Respir Cell Mol Biol (2003) 0.84
Structural analysis of the interaction between the side-chain of substrates and the active site of lanosterol 14 alpha-demethylase (P-450(14)DM) of yeast. Biochim Biophys Acta (1992) 0.79
Clinical analysis of pulmonary Mycobacterium avium complex disease in association with corticosteroid treatment. J Infect Chemother (2003) 0.77
Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection. Lancet (1993) 0.77
Relationship between porphyrin and isoniazid resistance of Mycobacterium avium. Nature (1958) 0.76
Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A (2005) 4.03
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol (2015) 2.95
Endurance exercise as a countermeasure for aging. Diabetes (2008) 2.83
Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol (2011) 2.76
A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis (2011) 2.50
Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest (2013) 2.21
Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol (2006) 1.93
Tuberculosis and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother (2009) 1.84
Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Chest (2002) 1.69
Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study. Mayo Clin Proc (2012) 1.50
Real-time PCR method for detection of zygomycetes. J Clin Microbiol (2008) 1.49
NHERF-2 maintains endothelial homeostasis. Blood (2012) 1.47
Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 1.44
Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol (2011) 1.36
Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis (2007) 1.35
Dermatophyte identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 1.32
Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia (2006) 1.26
Evaluation of the Sensititre MycoTB plate for susceptibility testing of the Mycobacterium tuberculosis complex against first- and second-line agents. J Clin Microbiol (2012) 1.24
Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth. J Natl Cancer Inst (2008) 1.22
Key inflammatory signaling pathways are regulated by the proteasome. Shock (2006) 1.21
Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients. Chest (2007) 1.19
Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol (2012) 1.12
Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures. J Clin Microbiol (2012) 1.04
Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigen. Med Mycol (2009) 1.03
Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card. J Clin Microbiol (2007) 1.03
Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity. Diagn Microbiol Infect Dis (2011) 1.02
Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech Ageing Dev (2008) 1.02
Identification of Mycobacterium species and Mycobacterium tuberculosis complex resistance determinants by use of PCR-electrospray ionization mass spectrometry. J Clin Microbiol (2013) 1.00
Analysis of ErbB receptors in pulmonary carcinoid tumors. Clin Cancer Res (2009) 0.99
Lung epithelial cells and extracellular matrix components induce expression of Pneumocystis carinii STE20, a gene complementing the mating and pseudohyphal growth defects of STE20 mutant yeast. Infect Immun (2003) 0.98
Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol (2006) 0.98
Advances in the biology, pathogenesis and identification of Pneumocystis pneumonia. Curr Opin Pulm Med (2008) 0.97
Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. Clin Cancer Res (2009) 0.96
Proteomic analysis of vascular endothelial cells in response to laminar shear stress. Proteomics (2007) 0.96
A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid. Diagn Microbiol Infect Dis (2006) 0.95
Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis (2011) 0.95
Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin Chest Med (2009) 0.95
Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea. Antioxid Redox Signal (2007) 0.91
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex for first and second line drugs by broth dilution in a microtiter plate format. J Vis Exp (2011) 0.91
Broad-range direct detection and identification of fungi by use of the PLEX-ID PCR-electrospray ionization mass spectrometry (ESI-MS) system. J Clin Microbiol (2013) 0.90
Increased expression of a disintegrin and metalloproteinase thrombospondin 1 in thrombosed hemodialysis grafts. J Vasc Interv Radiol (2008) 0.89
Expression analysis of PCSTE3, a putative pheromone receptor from the lung pathogenic fungus Pneumocystis carinii. Biochem Biophys Res Commun (2004) 0.89
Gordonia bacteremia. J Clin Microbiol (2013) 0.87
Detection of (1, 3)-β-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia (2012) 0.86
A cluster of Mycobacterium wolinskyi surgical site infections at an academic medical center. Infect Control Hosp Epidemiol (2014) 0.86
Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. Antimicrob Agents Chemother (2002) 0.85
Proteomic research: potential opportunities for clinical and physiological investigators. Am J Physiol Endocrinol Metab (2004) 0.84
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii. Am J Respir Cell Mol Biol (2003) 0.84
Pneumocystis carinii STE11, an HMG-box protein, is phosphorylated by the mitogen activated protein kinase PCM. Gene (2003) 0.84
Detection and identification of yeasts from formalin-fixed, paraffin-embedded tissue by use of PCR-electrospray ionization mass spectrometry. J Clin Microbiol (2013) 0.83
Microscopy of multiple visual receptor types in Drosophila. Mol Vis (2004) 0.82
The proteasome regulates bacterial CpG DNA-induced signaling pathways in murine macrophages. Shock (2010) 0.82
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis. J Med Microbiol (2011) 0.82
The utility of Coccidioides polymerase chain reaction testing in the clinical setting. Mycopathologia (2010) 0.81
Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR. J Clin Microbiol (2012) 0.81
Inflammation and infection in exacerbations of chronic obstructive pulmonary disease. Semin Respir Infect (2003) 0.80
Evaluation of Mycobacterium avium complex clarithromycin susceptibility testing using SLOMYCO Sensititre panels and JustOne strips. J Clin Microbiol (2010) 0.80
Complementation and characterization of the Pneumocystis carinii MAPK, PCM. FEBS Lett (2003) 0.79
Mycobacterium intermedium granulomatous dermatitis from hot tub exposure. Emerg Infect Dis (2006) 0.79
Genotypic characteristics of Mycobacterium tuberculosis isolated from household contacts of tuberculosis patients in the Philippines. BMC Infect Dis (2013) 0.79
Comparison of the FXG™: RESP (Asp+) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens. Med Mycol (2011) 0.79
Histoplasmosis and asplenia. Thorax (2010) 0.79
Preemployment screening for tuberculosis in a large health care setting: comparison of the tuberculin skin test and a whole-blood interferon-γ release assay. J Occup Environ Med (2011) 0.79
Advances in the treatment of rheumatic interstitial lung disease. Curr Opin Rheumatol (2004) 0.78
Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transpl (2006) 0.78
Pneumocystis carinii BCK1 complements the Saccharomyces cerevisiae cell wall integrity pathway. J Eukaryot Microbiol (2003) 0.78
Expression of profibrotic genes in a murine remnant kidney model. J Vasc Interv Radiol (2011) 0.77
Pneumocystis carinii BCK1 functions in a mitogen-activated protein kinase cascade regulating fungal cell-wall assembly. FEBS Lett (2003) 0.77
Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor. Med Mycol (2008) 0.76
Degree and frequency of inhibition in a routine real-time PCR detecting Pneumocystis jirovecii for the diagnosis of Pneumocystis pneumonia in Turkey. J Med Microbiol (2011) 0.76
Nontuberculous mycobacterial hypersensitivity pneumonitis related to a home shower: treatment and secondary prevention. BMJ Case Rep (2011) 0.76
Biochemical requirements for PCBCK1 kinase activity, the Pneumocystis carinii MEKK involved in cell wall integrity. FEMS Microbiol Lett (2004) 0.76
Hypersensitivity vasculitis with leukocytoclastic vasculitis associated with alpha-1-proteinase inhibitor. Case Rep Med (2010) 0.75
Against the ATS statement on human embryonic stem cell research. Am J Respir Crit Care Med (2006) 0.75
Meningeal coccidioidomycosis diagnosed by real-time polymerase chain reaction analysis of cerebrospinal fluid. Mycopathologia (2010) 0.75
Verification of antimicrobial susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2006) 0.75
Generation and sequencing of pulmonary carcinoid tumor cell lines. J Thorac Oncol (2014) 0.75
Complementation and in vivo biochemical characterization of the Pneumocystis carinii MAPK. J Eukaryot Microbiol (2003) 0.75
Mycobacteria. Microbiol Spectr (2016) 0.75
Wavelet compression of three-dimensional time-lapse biological image data. Microsc Microanal (2005) 0.75